Download Update on Prostate Cancer

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Update on Prostate Cancer
Senthil Kumaar
GP VTS teaching
Overview

Background & Statistics

Scenario 1 - Diagnosis & PSA testing

Scenario 2 – possible treatment options

Scenario 3 – important complications that
we should know

Summary
Background & Stats
How common is it ?
- Commonest cancer in men (25 % of all cancers in
men)
- 2nd commonest cancer death after lung in men
What are the risk factors ?
- Age
- Ethinicity – Black african/caribbean > White >
south Asian
- Family history
- BRCA gene mutation
No modifiable risk factors
Incidence
EU 27 – Age standardised incidence
and mortality rates
Trend
Age at diagnosis
Mortality rates
Office for National Statistics. Cancer Statistics Registrations, England
PSA screening – What’s the
evidence?
European RCT (ERSPC) – 9 yr interim results
 US study (PLCO) – 10 yr interim results

Number Needed to Screen (NNS) - 1400 men to
prevent one Pca death
Number needed to treat (NNT) – 48 men to
prevent one Pca death
UK verdict – No evidence that Benefits outweigh
harms
GP Scenario 1

60 yr old requesting PSA test
History ?
Counselling ??
Benefits & Harm of PSA testing
Benefits – early detection – early treatment - ? Extent
life / cure
Harms
 Unnecessary anxiety – only 1 in 3 with high PSA will
have Pca
 Unnecessary investigations – biopsy / imaging, only 1
in 3 of Pca are likely to be clinically significant
 Unnecessary treatment – may lead to treatment of
insignificant cancer which would not have clinically
evident in the man’s lifetime.
 False reassurance – 2 out of 10 may have normal PSA
and still have cancer.
When to suspect Pca ?
Unexplained
 Lower back pain
 Bone pain
 Wt loss in elderly
 ED
 Haematuria
Abnormal DRE
Raised PSA
When to offer PSA ?
Men > 50 , who ask for it
 Men with unexplained symptoms
 Men with obstructive LUTS

When to do PSA test ?
4 weeks after infection
 1 week after DRE
 48 hrs after exercise/ / ejaculation

Don’t forget DRE
www.prosdex.com
Counselling aid during consultation
Gp Scenario 2 – pt requesting your
opinion on treatment options
Gp Scenario 3 – pt presenting with
complications of Pca
Medical Emergency
- Spinal cord compression
- Acute / chronic retention
Summary





Increased incidence due to better diagnosis, but no
significant change in mortality rate
PSA national screening (UK policy) – Harm outweigh
benefits
Opportunistic PSA screening after appropriate
counselling
All treatment options have adverse effects including
active surveillence
All these might change in near future – UK 15 yr study
(ProTect trial) are publishing their results next year
(2013).